Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2022

View Archived Issues

OR6A2 is a therapeutic target for atherosclerosis, researchers unveil

Novel ester prodrugs of E-selectin antagonists with improved PK properties

New ENPP2 inhibitors identified at Suzhou Ark Biopharmaceutical

New PROTACs targeting androgen receptors sythesized at Sichuan Haisco Pharmaceutical

Abbisko Therapeutics discovers EGFR inhibtors

Shenzhen Salubris Pharmaceuticals patents ADAM-TS 5 inhibitors

Vitalixir presents new antidiabetic polypeptides

Researchers identify COPA as a prognostic marker and therapeutic target in cervical cancer

Acute intermittent porphyria treatment targets recombinant PBGD protein to the liver

DDO-02005, a novel potent Kv1.5 potassium channel inhibitor with antiarrhythmic activity

Novel CDK9 inhibitor inhibits osteosarcoma in patient-derived orthotopic xenografts

Loss of miR-15a/miR-16-1 contributes to CLL development

Ethris to advance mRNA-based therapeutics for respiratory diseases

Almirall signs agreements with Ablexis and AliviaMab to support work in dermatology

Celsion's DNA-based approach for SARS-CoV-2 vaccine to be studied in NHP challenge study

Drug cocktail is step up for leg regeneration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...